Genomic screening in children: BabyScreen+

Gene: LOX

Green List (high evidence)

LOX (lysyl oxidase, Ensemblv90)
EnsemblGeneIds (GRCh38): ENSG00000113083
EnsemblGeneIds (GRCh37): ENSG00000113083
OMIM: 153455, ClinGen, DECIPHER
LOX is in 1 panel

1 review

Zornitza Stark (Victorian Clinical Genetics Services)

Green List (high evidence)

Assessed as 'strong actionability' in paediatric patients by ClinGen.

FTAAD is a rare genetic vascular disease characterized by the familial occurrence of thoracic aortic aneurysm, dissection, or dilatation affecting one or more aortic segments (aortic root, ascending aorta, arch, or descending aorta).

Variable age of clinical presentation.

Prophylactic surgical repair of the aorta is recommended at 4.5-5.0 cm for patients with pathogenic variants in MYH11, SMAD3, and ACTA2 and at 4.0-4.5 cm for patients with pathogenic variants in TGFBR1 or TGFBR2.

Beta adrenergic-blocking agents are recommended to reduce aortic dilation. Losartan was added as an alternative to beta adrenergic-blocking agents in FTAAD after studies showed its efficacy in children and young adults with MFS who were randomly assigned to losartan or atenolol.

Penetrance: A study of 15 individuals with LOX pathogenic variants indicated that 73% had aortic aneurysms and 1 individual (7%) had an aortic dissection.
Sources: Expert Review
Created: 14 Aug 2025, 3:31 p.m.

Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted

Phenotypes
Aortic aneurysm, familial thoracic 10, MIM#617168

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Expert Review
Phenotypes
  • Aortic aneurysm, familial thoracic 10, MIM#617168
Tags
cardiac treatable
OMIM
153455
ClinGen
LOX
DECIPHER
LOX
Clinvar variants
Variants in LOX
Penetrance
None
Panels with this gene

History Filter Activity

Note: This information shows the history of the gene symbol, not the gene entity. Where the gene symbol for a gene has changed, this history may reference a different gene to the entry you are currently viewing.
14 Aug 2025, Gel status: 3

Added Tag, Added Tag

Zornitza Stark (Victorian Clinical Genetics Services)

Tag cardiac tag was added to gene: LOX. Tag treatable tag was added to gene: LOX.

14 Aug 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: lox has been classified as Green List (High Evidence).

14 Aug 2025, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services)

Gene: lox has been classified as Green List (High Evidence).

14 Aug 2025, Gel status: 1

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services)

gene: LOX was added gene: LOX was added to Genomic screening in children: BabyScreen+. Sources: Expert Review Mode of inheritance for gene: LOX was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Phenotypes for gene: LOX were set to Aortic aneurysm, familial thoracic 10, MIM#617168 Review for gene: LOX was set to GREEN